Botanical species · safety record

Apium graveolens

The EFSA Compendium of Botanicals holds 10 constituent measurements for Apium graveolens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Apium graveolens L.

10Constituent measurements
0Safety records
5Cited sources
401Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 401 licensed products naming Apium graveolens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh

Source material stated

  • Apium graveolens
  • Apium graveolens - Leaf stalk
  • Apium graveolens - seed
  • Apium graveolens var. dulce - whole plant
  • Branch(es)
  • Crushed seed
  • Fruit
  • Grain(s)

What the records describe

Constituents measured

  • Phthalides3
  • Furanocoumarins2
  • Bergapten1
  • Coumarins1
  • Nitrate1
  • Phenylpropanoids1
  • Psoralen1

Plant parts

  • Aerial part of plants3
  • Leaves3
  • Seed2
  • Live plants1
  • Roots and other underground parts1

Preparations

  • Solvent extraction7
  • Essential oil2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BergaptenAerial part of plantsSolvent extraction22 Microgram/gramGC-MSResolve DOI
CoumarinsLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
FuranocoumarinsAerial part of plantsSolvent extraction55 Microgram/gramGC-MSResolve DOI
FuranocoumarinsRoots and other underground partsSolvent extraction45 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
NitrateLive plants> 2500 Milligram/kilogramUnspecifiedResolve DOI
PhenylpropanoidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PhthalidesSeedEssential oil3 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PhthalidesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PhthalidesSeedEssential oil3.9 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PsoralenAerial part of plantsSolvent extraction47 Microgram/gramGC-MSResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Santamaria, P. Nitrate in vegetables: toxicity, content, intake and EC regulation. Journal of the science of food and agriculture, 2006, vol. 86, no. 1, p. 10-17. DOI
  2. Peroutka, Radek., Schulzova, Vera., Botek, Petr., Hajslova, Jana. Analysis of furanocoumarins in vegetables (Apiaceae) anal citrus fruits (Rutaceae). JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2007, vol. 87, no. 11, p. 2152-2163. DOI
  3. Sbai, H., Zribi, I., DellaGreca, M., Haouala, R. Bioguided fractionation and isolation of phytotoxic compounds from Apium graveolens L. aerial parts (Apiaceae). South african journal of botany, 2017, vol. 108, p. 423-430. DOI
  4. ZHENG, GQ., KENNEY, PM., ZHANG, JL., LAM, LKT. CHEMOPREVENTION OF BENZO A PYRENE-INDUCED FORESTOMACH CANCER IN MICE BY NATURAL PHTHALIDES FROM CELERY SEED OIL. Nutrition and cancer-an international journal, 1993, vol. 19, no. 1, p. 77-86. DOI
  5. ZOBEL, AM., WANG, JY., MARCH, RE., BROWN, SA. IDENTIFICATION OF 8 COUMARINS OCCURRING WITH PSORALEN, XANTHOTOXIN, AND BERGAPTEN ON LEAF SURFACES . Journal of chemical ecology, 1991, vol. 17, no. 9, p. 1859-1870. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue